Two biotech companies, Exact Sciences and Guardant Health, engaged in a heated public rivalry on social media over the development of new colon cancer screening tests. Guardant Health’s co-CEO challenged Exact Sciences’ CEO to a $1M bet on the accuracy of Exact’s data on their blood-based colon cancer test. The challenge was made prior to Exact Sciences presenting their data at a medical oncology conference. This public confrontation between the two companies is unusual in the biotech industry, where competition is common but typically not as openly confrontational.
Source link
Colon cancer blood test competition spills over to social media
